<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK47312" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK47312/" /><meta name="ncbi_pagename" content="Legius Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Legius Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Legius Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/01/15" /><meta name="citation_author" content="David Stevenson" /><meta name="citation_author" content="David Viskochil" /><meta name="citation_author" content="Rong Mao" /><meta name="citation_pmid" content="20945555" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK47312/" /><meta name="citation_keywords" content="Neurofibromatosis Type 1-Like Syndrome" /><meta name="citation_keywords" content="Neurofibromatosis Type 1-Like Syndrome" /><meta name="citation_keywords" content="Sprouty-related, EVH1 domain-containing protein 1" /><meta name="citation_keywords" content="SPRED1" /><meta name="citation_keywords" content="Legius Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Legius Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="David Stevenson" /><meta name="DC.Contributor" content="David Viskochil" /><meta name="DC.Contributor" content="Rong Mao" /><meta name="DC.Date" content="2015/01/15" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK47312/" /><meta name="description" content="Legius syndrome is characterized by multiple café au lait macules without neurofibromas or other tumor manifestations of neurofibromatosis type 1 (NF1). Additional clinical manifestations reported commonly include intertriginous freckling, lipomas, macrocephaly, and learning disabilities / ADHD / developmental delays. Current knowledge of the natural history of Legius syndrome is based on the clinical manifestations of fewer than 200 individuals with a molecularly confirmed diagnosis; better delineation of the clinical manifestations and natural history of Legius syndrome will likely occur as more affected individuals are identified." /><meta name="og:title" content="Legius Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Legius syndrome is characterized by multiple café au lait macules without neurofibromas or other tumor manifestations of neurofibromatosis type 1 (NF1). Additional clinical manifestations reported commonly include intertriginous freckling, lipomas, macrocephaly, and learning disabilities / ADHD / developmental delays. Current knowledge of the natural history of Legius syndrome is based on the clinical manifestations of fewer than 200 individuals with a molecularly confirmed diagnosis; better delineation of the clinical manifestations and natural history of Legius syndrome will likely occur as more affected individuals are identified." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK47312/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/legius/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK47312/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D6F4FE040482100000000082102DF.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK47312_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK47312_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lhon/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lenz/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK47312_"><span class="title" itemprop="name">Legius Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Neurofibromatosis Type 1-Like Syndrome</div><p class="contrib-group"><span itemprop="author">David Stevenson</span>, MD, <span itemprop="author">David Viskochil</span>, MD, PhD, and <span itemprop="author">Rong Mao</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK47312_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK47312_ai__"><div class="contrib half_rhythm"><span itemprop="author">David Stevenson</span>, MD<div class="affiliation small">Stanford University<br />Stanford, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.drofnats@nevetsad" class="oemail">ude.drofnats@nevetsad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">David Viskochil</span>, MD, PhD<div class="affiliation small">University of Utah<br />Salt Lake City, Utah<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.hatu.csh@lihcoksiv.evad" class="oemail">ude.hatu.csh@lihcoksiv.evad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Rong Mao</span>, MD<div class="affiliation small">University of Utah<br />Salt Lake City, Utah<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.balpura@oam.gnor" class="oemail">moc.balpura@oam.gnor</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 14, 2010</span>; Last Update: <span itemprop="dateModified">January 15, 2015</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="legius.Summary" itemprop="description"><h2 id="_legius_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Legius syndrome is characterized by multiple caf&#x000e9; au lait macules without neurofibromas or other tumor manifestations of neurofibromatosis type 1 (NF1). Additional clinical manifestations reported commonly include intertriginous freckling, lipomas, macrocephaly, and learning disabilities / ADHD / developmental delays. Current knowledge of the natural history of Legius syndrome is based on the clinical manifestations of fewer than 200 individuals with a molecularly confirmed diagnosis; better delineation of the clinical manifestations and natural history of Legius syndrome will likely occur as more <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are identified.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Legius syndrome is difficult to make on clinical grounds alone. Detection of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SPRED1</i>, the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with Legius syndrome, is necessary to confirm the diagnosis.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Consideration of behavioral modification and/or pharmacologic therapy for those with ADHD; physical, speech, and occupational therapy for those with identified developmental delays; individualized education plans for those with learning disorders.</p><p><i>Surveillance:</i> Routine screening for developmental delays and behavioral and learning problems.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Legius syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Each child of an individual with Legius syndrome has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Although uncommonly requested, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk is possible if the <i>SPRED1</i> pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p></div></div><div id="legius.Diagnosis"><h2 id="_legius_Diagnosis_">Diagnosis</h2><div id="legius.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Diagnosis of Legius syndrome should be suspected in an individual who:</p><ul><li class="half_rhythm"><div>Has pigmentary dysplasia consisting of caf&#x000e9; au lait macules, with or without intertriginous freckling; and</div></li><li class="half_rhythm"><div>Lacks the non-pigmentary clinical diagnostic manifestations of neurofibromatosis type 1 (NF1) (e.g., Lisch nodules, neurofibromas, optic nerve glioma, sphenoid wing dysplasia, long bone dysplasia); and</div></li><li class="half_rhythm"><div>Has a parent with multiple caf&#x000e9; au lait macules but no other features of NF1.</div></li></ul><p>Additional clinical manifestations reported in multiple individuals are listed in <a class="figpopup" href="/books/NBK47312/table/legius.T.additional_findings_reported_in/?report=objectonly" target="object" rid-figpopup="figlegiusTadditionalfindingsreportedin" rid-ob="figoblegiusTadditionalfindingsreportedin">Table 2</a>.</p></div><div id="legius.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Legius syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SPRED1</i> (see <a class="figpopup" href="/books/NBK47312/table/legius.T.summary_of_molecular_genetic_te/?report=objectonly" target="object" rid-figpopup="figlegiusTsummaryofmoleculargeneticte" rid-ob="figoblegiusTsummaryofmoleculargeneticte">Table 1</a>).</p><p><b>Molecular testing approaches</b> can include:</p><ul><li class="half_rhythm"><div class="half_rhythm">Sequence analysis of <i>SPRED1</i> first, followed by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found;</div></li><li class="half_rhythm"><div class="half_rhythm">Use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>SPRED1</i> and other genes of interest (see <a href="#legius.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><p>Note: Opinions differ on the appropriate approach when clinical information and family history cannot distinguish between NF1 and Legius syndrome. The assessment of pros and cons of molecular testing requires consideration of the circumstances unique to each individual, including (but not limited to) the following:</p><ul><li class="half_rhythm"><div>Clinical findings and family history</div></li><li class="half_rhythm"><div>Age of the individual</div></li><li class="half_rhythm"><div>Differences in recommended clinical management when the diagnosis of NF1 or Legius syndrome is established with certainty versus when the diagnosis of neither can be established with confidence</div></li><li class="half_rhythm"><div>Psychological burden of a diagnosis or lack thereof</div></li><li class="half_rhythm"><div>Costs of testing and surveillance</div></li></ul><p>For various approaches, see <a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al [2009]</a>, <a class="bk_pop" href="#legius.REF.pasmant.2009.1131">Pasmant et al [2009]</a>, <a class="bk_pop" href="#legius.REF.stevenson.2009.2150">Stevenson &#x00026; Viskochil [2009]</a>, <a class="bk_pop" href="#legius.REF.muramzborovski.2010.1203">Muram-Zborovski et al [2010]</a>, <a class="bk_pop" href="#legius.REF.denayer.2011a.e1985">Denayer et al [2011a]</a>, <a class="bk_pop" href="#legius.REF.brems.2012.1538">Brems et al [2012]</a>.</p><div id="legius.T.summary_of_molecular_genetic_te" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Summary of Molecular Genetic Testing Used in Legius Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47312/table/legius.T.summary_of_molecular_genetic_te/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__legius.T.summary_of_molecular_genetic_te_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPRED1</i></td><td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">88%&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td><td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_legius.T.summary_of_molecular_genetic_te_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="legius.TF.1.1"><p class="no_margin">See <a href="/books/NBK47312/#legius.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#legius.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="legius.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="legius.TF.1.3"><p class="no_margin">Of individuals evaluated for NF1 without an identifiable <i>NF1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, 3%-25% had an identifiable <i>SPRED1</i> pathogenic variant [<a class="bk_pop" href="#legius.REF.brems.2007.1120">Brems et al 2007</a>, <a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al 2009</a>, <a class="bk_pop" href="#legius.REF.pasmant.2009.1131">Pasmant et al 2009</a>, <a class="bk_pop" href="#legius.REF.spurlock.2009.431">Spurlock et al 2009</a>]. Sequence analysis should identify the majority of individuals without whole <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions, although it is estimated that approximately 1%-2% could have deep <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> variants which could be missed, but this has not been reported.</p></div></dd><dt>4. </dt><dd><div id="legius.TF.1.4"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>5. </dt><dd><div id="legius.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#legius.REF.spencer.2011.1352">Spencer et al [2011]</a> report that deletions comprise approximately 10% of <i>SPRED1</i> pathogenic variants and include multiexon deletions and whole <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions</p></div></dd><dt>6. </dt><dd><div id="legius.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al [2009]</a> reported on a cohort of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases with similar phenotypes and 73% had pathogenic variants in <i>NF1</i> and 19% had a <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, suggesting that other loci are possible for an overlapping pigmentary <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. In addition, several families with multiple caf&#x000e9; au lait macules inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pattern have been described [<a class="bk_pop" href="#legius.REF.brunner.1993.472">Brunner et al 1993</a>, <a class="bk_pop" href="#legius.REF.charrow.1993.606">Charrow et al 1993</a>, <a class="bk_pop" href="#legius.REF.arnsmeier.1994.1425">Arnsmeier et al 1994</a>, <a class="bk_pop" href="#legius.REF.abeliovich.1995.985">Abeliovich et al 1995</a>, <a class="bk_pop" href="#legius.REF.nystr_m.2009b.693">Nystr&#x000f6;m et al 2009b</a>].</p></div></dd></dl></div></div></div></div></div><div id="legius.Clinical_Characteristics"><h2 id="_legius_Clinical_Characteristics_">Clinical Characteristics</h2><div id="legius.Clinical_Description"><h3>Clinical Description</h3><p>The natural history of Legius syndrome is based on the clinical manifestations of a few series of individuals with <i>SPRED1</i> pathogenic variants and their extended families. Additional less common manifestations are listed in <a class="figpopup" href="/books/NBK47312/table/legius.T.additional_findings_reported_in/?report=objectonly" target="object" rid-figpopup="figlegiusTadditionalfindingsreportedin" rid-ob="figoblegiusTadditionalfindingsreportedin">Table 2</a>. Better delineation of the clinical manifestations and natural history of Legius syndrome will likely occur as more <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are identified and followed prospectively.</p><p>Of note, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Legius syndrome is based on the reports of relatively few (&#x0003c;200) individuals, in which the primary focus was on individuals with the overlapping pigmentary manifestations of <a href="/books/n/gene/nf1/">neurofibromatosis type 1</a> (NF1).</p><p><b>Skin findings.</b> Almost invariably, individuals with Legius syndrome present with caf&#x000e9; au lait macules. In some instances, freckling of the axillary/groin region is present. Two individuals (a male age 60 years and a child age 2 years), each with a presumed pathogenic <i>SPRED1</i> variant, have been reported with no caf&#x000e9; au lait macules or freckling [<a class="bk_pop" href="#legius.REF.brems.2007.1120">Brems et al 2007</a>, <a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al 2009</a>]. The lack of pigmentary manifestations in the two-year-old was possibly a result of the child's young age. The number of caf&#x000e9; au lait macules increases with age in childhood, similar to what is observed in NF1 [Author, personal observation].</p><p><b>Macrocephaly.</b> Absolute or relative macrocephaly has been seen in children and adults with Legius syndrome. However, the frequency of macrocephaly varied in different reports: head circumference was at or above the 97th centile in approximately 40% of individuals in one cohort [<a class="bk_pop" href="#legius.REF.brems.2007.1120">Brems et al 2007</a>] but above the 95th centile in only one of 18 individuals in another cohort [<a class="bk_pop" href="#legius.REF.pasmant.2009.1131">Pasmant et al 2009</a>].</p><p><b>Stature.</b> Absolute short stature has not been frequently noted in most series (although <a class="bk_pop" href="#legius.REF.denayer.2011a.e1985">Denayer et al [2011a]</a> reported it in 31%). <a class="bk_pop" href="#legius.REF.brems.2007.1120">Brems et al [2007]</a> reported that in 52% of individuals, height was greater than the 50th centile. Growth charts for Legius syndrome have not been published.</p><p><b>Neurobehavioral and developmental problems</b> are observed in individuals with Legius syndrome, but in many instances detailed descriptions are lacking. <a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al [2009]</a> reported three individuals who had hyperactivity and two who had attention deficits. Of the six individuals with developmental abnormalities described by <a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al [2009]</a>, all had speech and/or language delays as the primary or only delay. In the 12 individuals with Legius syndrome described by <a class="bk_pop" href="#legius.REF.spurlock.2009.431">Spurlock et al [2009]</a>, no learning or developmental problems were noted in the probands. <a class="bk_pop" href="#legius.REF.denayer.2011a.e1985">Denayer et al [2011a]</a> described five children with motor delay and five with speech delay, three individuals with ADHD, and 14 of 25 individuals with learning difficulties.</p><p>The cognitive <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in Legius syndrome is likely milder than that observed in NF1. A study of 15 individuals with Legius syndrome by <a class="bk_pop" href="#legius.REF.denayer.2011b.123">Denayer et al [2011b]</a> showed a lower performance IQ in children with Legius syndrome compared to their unaffected family members, although the full-scale IQ did not differ. <a class="bk_pop" href="#legius.REF.laycockvan_spyk.2011.93">Laycock-van Spyk et al [2011]</a> reported one individual with cognitive impairment with an IQ of 68.</p><p><b>Brain imaging.</b> Two individuals had T<sub>2</sub>-weighted hyperintense lesions on brain imaging; thus, the presence of such lesions cannot be used to differentiate between Legius syndrome and NF1 [<a class="bk_pop" href="#legius.REF.denayer.2011a.e1985">Denayer et al 2011a</a>].</p><p><b>Vascular anomalies.</b> A small number of vascular anomalies have been reported, but the descriptions are incomplete and different in each instance. The vascular abnormalities were listed as "tuberous hemangioma," "inguinal hemangioma," "large right temporal venous anomaly in brain," and "vascular anomaly left lower leg." Additional data are needed to determine if these reported vascular anomalies are tumors or malformations, and whether there is an increase of vascular anomalies in Legius syndrome.</p><p><b>Other.</b> See <a class="figpopup" href="/books/NBK47312/table/legius.T.additional_findings_reported_in/?report=objectonly" target="object" rid-figpopup="figlegiusTadditionalfindingsreportedin" rid-ob="figoblegiusTadditionalfindingsreportedin">Table 2</a>. Examples of other findings reported in <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> or only a few individuals include fifth finger clinodactyly, Chiari I malformation, hypotonia, cataract, nephrolithiasis, urethral meatal stenosis, pulmonic stenosis and mitral valve prolapse, paroxysmal atrial tachycardia, tubular colonic adenoma, progressive dystonia, xanthelasmas, desmoid tumor, vestibular schwanomma, tenosynovial giant cell tumor, dermoid tumor of the ovary, non-small cell lung cancer, Wilms tumor, and monoblastic acute leukemia. Observations of clinical findings in a single individual should be taken with caution because chance occurrence cannot be distinguished from specific disease associations.</p><div id="legius.T.additional_findings_reported_in" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Additional Findings Reported in Multiple Individuals in Studies of Legius Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47312/table/legius.T.additional_findings_reported_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__legius.T.additional_findings_reported_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" rowspan="3" scope="col" colspan="1" headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Finding</th><th id="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" colspan="8" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Study</th></tr><tr><th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#legius.REF.brems.2007.1120">Brems et al [2007]</a> (n=44)</th><th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#legius.REF.pasmant.2009.1131">Pasmant et al [2009]</a> (n=18)</th><th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#legius.REF.spurlock.2009.431">Spurlock et al [2009]</a> (n=12)</th><th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al [2009]</a> (n=40)&#x000a0;<sup>1</sup></th><th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#legius.REF.muramzborovski.2010.1203">Muram-Zborovski et al [2010]</a> (n=2)</th><th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#legius.REF.denayer.2011a.e1985">Denayer et al [2011a]</a> (n=30)</th><th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#legius.REF.spencer.2011.1352">Spencer et al [2011]</a> (n=7)</th><th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2" id="hd_h_legius.T.additional_findings_reported_in_1_1_2_8" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#legius.REF.laycockvan_spyk.2011.93">Laycock-van Spyk et al [2011]</a> (n=10)</th></tr><tr><th headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_2_8" id="hd_h_legius.T.additional_findings_reported_in_1_1_3_1" colspan="8" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Number of persons by study in whom finding was observed&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Macrocephaly</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Short stature (&#x0003c;5th centile)</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Noonan-syndrome-like facies</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pectus anomalies</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Depigmented macules</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Vascular lesions</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Lipomas</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2&#x000a0;<sup>3</sup></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Learning disabilities / ADHD / developmental delays</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">16</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6</td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Headaches</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing loss</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizures</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Polydactyly</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Scoliosis</b></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_1 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_2 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_3 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_4 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_5 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_6 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_7 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_legius.T.additional_findings_reported_in_1_1_1_2 hd_h_legius.T.additional_findings_reported_in_1_1_2_8 hd_h_legius.T.additional_findings_reported_in_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ADHD = attention-deficit/hyperactivity disorder</p></div></dd><dt>1. </dt><dd><div id="legius.TF.2.1"><p class="no_margin">Clinical cohort (cohort 1). Data from Anonymous cohort are not included due to potential overlap.</p></div></dd><dt>2. </dt><dd><div id="legius.TF.2.2"><p class="no_margin">Absence of clinical findings was not always reported; hence, numbers represent only data that were reported in the respective articles.</p></div></dd><dt>3. </dt><dd><div id="legius.TF.2.3"><p class="no_margin">Includes angiolipoma</p></div></dd></dl></div></div></div><p><b>Tumor risk.</b> Legius syndrome in general lacks the tumor manifestations typically observed in NF1 (i.e., Lisch nodules, neurofibromas, and central nervous system tumors). One group has suggested that individuals with Legius syndrome are at an increased risk for leukemia [<a class="bk_pop" href="#legius.REF.pasmant.2009.1131">Pasmant et al 2009</a>, <a class="bk_pop" href="#legius.REF.pasmant.2015.631">Pasmant et al 2015</a>]. There has been a report of acute myeloblastic leukemia in one individual by <a class="bk_pop" href="#legius.REF.pasmant.2009.1131">Pasmant et al [2009]</a>, and this group subsequently screened 230 pediatric lymphoblastic and acute myeloblastic leukemias and found a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> frameshift <i>SPRED1</i> variant in a patient with Legius syndrome, but no other <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the cohort [<a class="bk_pop" href="#legius.REF.pasmant.2015.631">Pasmant et al 2015</a>]. However, in the one patient, the <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> of white blood cell blasts showed a <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-heterozygosity/">loss of heterozygosity</a> [<a class="bk_pop" href="#legius.REF.pasmant.2015.631">Pasmant et al 2015</a>]. In addition, SPRED1 protein and <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> levels were decreased in the majority of acute myeloblastic leukemias at diagnosis [<a class="bk_pop" href="#legius.REF.pasmant.2015.631">Pasmant et al 2015</a>]. Further studies are needed to assess the potential risk for cancers in Legius syndrome, particularly given that <i>SPRED1</i> is part of the RAS-MAPK signal transduction pathway, a pathway involved in several neoplasms.</p></div><div id="legius.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>To date no <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been documented.</p></div><div id="legius.Penetrance"><h3>Penetrance</h3><p>The vast majority of individuals with <i>SPRED1</i> pathogenic variants have caf&#x000e9; au lait macules and/or freckling; however, the age of pigment <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is not established. Only two individuals (a 60-year-old male and a 2-year-old child), each with a presumed <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, were reported not to have caf&#x000e9; au lait macules or freckling [<a class="bk_pop" href="#legius.REF.brems.2007.1120">Brems et al 2007</a>, <a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al 2009</a>].</p></div><div id="legius.Anticipation"><h3>Anticipation</h3><p>No evidence for <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> exists.</p></div><div id="legius.Nomenclature"><h3>Nomenclature</h3><p>Individuals with <i>SPRED1</i> pathogenic variants were initially described as having "neurofibromatosis type 1-like syndrome" (NFLS) &#x02013; primarily because of the observation that the findings in many fulfilled the current NIH NF1 clinical diagnostic criteria, even though based solely on pigmentary findings [<a class="bk_pop" href="#legius.REF.brems.2007.1120">Brems et al 2007</a>]. Although <i>NF1</i> and <i>SPRED1</i> interact within the same signal transduction pathway, the majority of individuals with <i>SPRED1</i> pathogenic variants share the pigmentary manifestations but lack the tumor findings associated with NF1. To clearly delineate this point in counseling sessions and to avoid confusion between NF1 and NF1-like syndrome, experts at the 13th European Neurofibromatosis Meeting (2008) suggested that the disorder be named "Legius syndrome" after Eric Legius, the senior author of the publication that first described the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>SPRED1</i> pathogenic variants in humans [<a class="bk_pop" href="#legius.REF.brems.2007.1120">Brems et al 2007</a>].</p></div><div id="legius.Prevalence"><h3>Prevalence</h3><p>The prevalence of Legius syndrome is not known, but in two studies approximately 2% of individuals fulfilling diagnostic criteria for NF1 have had <i>SPRED1</i> pathogenic variants [<a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al 2009</a>, <a class="bk_pop" href="#legius.REF.muramzborovski.2010.1203">Muram-Zborovski et al 2010</a>]. The incidence of NF1 is reported to be 1:3000 [<a class="bk_pop" href="#legius.REF.friedman.1997.138">Friedman &#x00026; Birch 1997</a>].</p></div></div><div id="legius.Genetically_Related_Allelic_Disor"><h2 id="_legius_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>SPRED1.</i></p></div><div id="legius.Differential_Diagnosis"><h2 id="_legius_Differential_Diagnosis_">Differential Diagnosis</h2><p>Of primary importance in the clinical delineation of Legius syndrome is establishing the absence of other manifestations associated with the large number of other syndromes with multiple caf&#x000e9; au lait macules. Although the diagnosis of Legius syndrome is difficult to make clinically with certainty without identification of a <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the lack of additional clinical features, especially in older individuals, can help to differentiate Legius syndrome from other conditions.</p><p><a href="/books/n/gene/nf1/"><b>Neurofibromatosis 1</b></a>
<b>(NF1)</b> is most frequently confused with Legius syndrome, as some individuals with Legius syndrome fulfill the clinical diagnostic criteria for NF1 [<a class="bk_pop" href="#legius.REF.nih.1988.172">NIH 1988</a>, <a class="bk_pop" href="#legius.REF.gutmann.1997.51">Gutmann et al 1997</a>]. Approximately 3%-25% of individuals being evaluated for NF1 who do not have an identifiable <i>NF1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a <i>SPRED1</i> pathogenic variant [<a class="bk_pop" href="#legius.REF.brems.2007.1120">Brems et al 2007</a>, <a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al 2009</a>, <a class="bk_pop" href="#legius.REF.pasmant.2009.1131">Pasmant et al 2009</a>, <a class="bk_pop" href="#legius.REF.spurlock.2009.431">Spurlock et al 2009</a>]. The vast majority of individuals with NF1 eventually develop Lisch nodules and neurofibromas, but these manifestations are age-related, making the clinical distinction of NF1 from Legius syndrome very difficult in young children. The non-pigmentary manifestations outlined in the NIH NF1 diagnostic criteria (e.g., Lisch nodules, neurofibromas, optic pathway gliomas, sphenoid wing dysplasia, long-bone dysplasia) have not been observed in individuals with Legius syndrome, and the presence of one of these manifestations differentiates NF1 from Legius syndrome. Caution is needed when trying to establish a diagnosis of NF1 based purely on pigmentary findings [<a class="bk_pop" href="#legius.REF.stevenson.2009.2150">Stevenson &#x00026; Viskochil 2009</a>].</p><p>The phenotypes associated with specific <i>NF1</i> pathogenic variants are similar to Legius syndrome in many cases. A described <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation with the <i>NF1</i> three-base-pair <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> resulting in removal of a methionine residue (c.2970_2972delAAT in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 22 using NCBI nomenclature) results in an attenuated NF1 phenotype with relative lack of neurofibromas [<a class="bk_pop" href="#legius.REF.stevenson.2006.246">Stevenson et al 2006</a>, <a class="bk_pop" href="#legius.REF.upadhyaya.2007.140">Upadhyaya et al 2007</a>]. An <i>NF1</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant (p.Leu1390Phe) was observed in a single multigenerational family that lacked neurofibromas and had features of Noonan syndrome with variable presence of Lisch nodules; however, the possible contribution of other modifiers cannot be excluded [<a class="bk_pop" href="#legius.REF.nystr_m.2009a.524">Nystr&#x000f6;m et al 2009a</a>].</p><p><a href="/books/n/gene/noonan/"><b>Noonan syndrome</b></a><b>.</b> While individuals with Noonan syndrome occasionally have caf&#x000e9; au lait macules, they do not typically have them in large numbers. Some individuals with <i>SPRED1</i> pathogenic variants have been reported to have facial features consistent with Noonan syndrome, and at least one individual with Legius syndrome was previously diagnosed as having Noonan syndrome [<a class="bk_pop" href="#legius.REF.brems.2007.1120">Brems et al 2007</a>]. Congenital heart disease is common in Noonan syndrome but has not been a consistent finding in Legius syndrome.</p><p><b>Autosomal dominant caf&#x000e9; au lait spots</b> (OMIM <a href="http://omim.org/entry/114030" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">114030</a>). Several families with multiple caf&#x000e9; au lait macules inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pattern have been described [<a class="bk_pop" href="#legius.REF.brunner.1993.472">Brunner et al 1993</a>, <a class="bk_pop" href="#legius.REF.charrow.1993.606">Charrow et al 1993</a>, <a class="bk_pop" href="#legius.REF.arnsmeier.1994.1425">Arnsmeier et al 1994</a>, <a class="bk_pop" href="#legius.REF.abeliovich.1995.985">Abeliovich et al 1995</a>, <a class="bk_pop" href="#legius.REF.nystr_m.2009b.693">Nystr&#x000f6;m et al 2009b</a>]. It is possible that some of these families harbor a <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, although this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in at least one family did not segregate with markers within the SPRED1 <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> [<a class="bk_pop" href="#legius.REF.nystr_m.2009b.693">Nystr&#x000f6;m et al 2009b</a>].</p><p>Other conditions associated with multiple caf&#x000e9; au lait macules include multiple lentigines syndrome (also known as <a href="/books/n/gene/leopard/">LEOPARD syndrome</a>), <a href="/books/n/gene/mccune-albright/">McCune-Albright syndrome</a>, <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/mismatch-repair/">mismatch repair</a> cancer syndrome (see <a href="/books/n/gene/hnpcc/">Hereditary Non-Polyposis Colon Cancer</a>), <a href="/books/n/gene/bloom/">Bloom syndrome</a>, <a href="/books/n/gene/fa/">Fanconia anemia</a>, <a href="/books/n/gene/rss/">Silver-Russell syndrome</a>, Bannayan-Riley-Ruvalcaba syndrome (see <a href="/books/n/gene/phts/"><i>PTEN</i> Hamartoma Tumor Syndrome</a>), <a href="/books/n/gene/costello/">Costello syndrome</a>, <a href="/books/n/gene/cfc/">cardiofaciocutaneous syndrome</a>, and <a href="/books/n/gene/tuberous-sclerosis/">tuberous sclerosis complex</a>.</p></div><div id="legius.Management"><h2 id="_legius_Management_">Management</h2><div id="legius.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual with a confirmed molecular diagnosis of Legius syndrome, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Age-appropriate developmental assessment</div></li><li class="half_rhythm"><div>Neuropsychiatric evaluation on entry into school system or sooner based on clinical findings</div></li><li class="half_rhythm"><div>Detailed dermatologic evaluation for supportive findings</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="legius.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Consideration of behavioral modification or pharmacologic adjuvant therapy for individuals with ADHD</div></li><li class="half_rhythm"><div>Adjuvant therapies such as physical, speech, and occupational therapy for individuals with identified developmental delays</div></li><li class="half_rhythm"><div>Individualized education plans for learning disorders and school performance issues</div></li></ul></div><div id="legius.Prevention_of_Secondary_Complicat"><h3>Prevention of Secondary Complications</h3><p>Age-appropriate developmental assessment and neuropsychiatric evaluations could potentially result in the initiation of therapies to prevent developmental and behavioral complications.</p></div><div id="legius.Surveillance"><h3>Surveillance</h3><p>Consider periodic evaluation by a clinical geneticist to discuss manifestations associated with disorders of the Ras/MAPK pathway that may eventually be associated with Legius syndrome</p><p>Routine screening for developmental delays and behavioral and learning problems is appropriate.</p><p>Although vascular abnormalities have been reported in a few individuals with Legius syndrome, hypertension has not been reported. However, given the prevalence of vascular abnormalities and hypertension in NF1, it would seem appropriate to have regular blood pressure monitoring at each physician visit.</p></div><div id="legius.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Using <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, it is appropriate to evaluate relatives at risk (e.g., parents, younger and older sibs of a proband) with caf&#x000e9; au lait macules to identify as early as possible those who could benefit from institution of treatment and preventive measures.</p><p>See <a href="#legius.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="legius.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="legius.Genetic_Counseling"><h2 id="_legius_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="legius.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Legius syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="legius.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Many individuals diagnosed with Legius syndrome have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with Legius syndrome may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Because the majority of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) have not been evaluated sufficiently to determine if the pathogenic variant occurred <i>de novo</i>, the proportion of Legius syndrome caused by <i>de novo</i> pathogenic variants is not well elucidated. However, one report states that six of 23 probands with <i>SPRED1</i> pathogenic variants in a clinical cohort had <i>de novo</i> variants [<a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al 2009</a>].</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, as with any <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition, it remains a possibility.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with Legius syndrome may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless physical examination by a clinical geneticist and <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the pathogenic variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, although this has not been reported to date for Legius syndrome.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for Legius syndrome because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent.</div></li><li class="half_rhythm"><div>If the <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low, but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with Legius syndrome has a 50% chance of inheriting the <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members</b></p><ul><li class="half_rhythm"><div>The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents.</div></li><li class="half_rhythm"><div>If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</div></li></ul></div><div id="legius.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#legius.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with Legius syndrome has the pathogenic variant or clinical evidence of the disorder, it is likely that the variant occurred <i>de novo</i> in the proband. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="legius.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SPRED1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for Legius syndrome are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="legius.Resources"><h2 id="_legius_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Legius%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Legius syndrome</a></div></li><li class="half_rhythm"><div><b>RASopathiesNet</b></div><div>244 Taos Road</div><div>Atlandena CA 91001</div><div><b>Phone:</b> 626-676-7694</div><div><b>Email:</b> lisa@rasopathies.org</div><div><a href="http://rasopathiesnet.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rasopathiesnet.org</a></div></li><li class="half_rhythm"><div><b>Children's Tumor Foundation</b></div><div>95 Pine Street</div><div>16th Floor</div><div>New York NY 10005</div><div><b>Phone:</b> 800-323-7938 (toll-free); 212-344-6633</div><div><b>Fax:</b> 212-747-0004</div><div><b>Email:</b> info@ctf.org</div><div><a href="http://www.ctf.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ctf.org</a></div></li></ul></div><div id="legius.Molecular_Genetics"><h2 id="_legius_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="legius.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Legius Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47312/table/legius.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__legius.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_legius.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_legius.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_legius.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_legius.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_legius.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_legius.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_legius.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/161742" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SPRED1</i></a></td><td headers="hd_b_legius.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=161742" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q14</a></td><td headers="hd_b_legius.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q7Z699" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sprouty-related, EVH1 domain-containing protein 1</a></td><td headers="hd_b_legius.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.arup.utah.edu/database/SPRED1/SPRED1_welcome.php" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Legius Syndrome and SPRED1</a><br /><a href="http://www.lovd.nl/SPRED1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPRED1 @ LOVD</a><br /><a href="http://databases.lovd.nl/shared/genes/SPRED1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPRED1 database</a></td><td headers="hd_b_legius.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SPRED1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPRED1</a></td><td headers="hd_b_legius.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SPRED1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPRED1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="legius.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="legius.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Legius Syndrome (<a href="/omim/609291,611431" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47312/table/legius.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__legius.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609291" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609291</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPROUTY-RELATED EVH1 DOMAIN-CONTAINING PROTEIN 1; SPRED1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611431" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611431</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LEGIUS SYNDROME; LGSS</td></tr></tbody></table></div></div><div id="legius.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>SPRED1</i> encodes a protein that negatively regulates Ras-MAPK signaling. Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in <i>SPRED1</i> create mutated Spred1 proteins incapable of inhibiting Raf1 kinase activation. This results in attenuated inhibition of downstream Raf-MEK-ERK signaling [<a class="bk_pop" href="#legius.REF.brems.2007.1120">Brems et al 2007</a>]. This uninhibited signaling and consequent increase in Ras signal propagation is similar to that observed in NF1 and likely results in the clinical overlap of these two conditions.</p><p>For example, neurobehavioral problems are reported in individuals with Legius syndrome and NF1; this finding in Legius syndrome is biologically consistent with data in the mouse model showing that Spred1 protein is required for synaptic plasticity [<a class="bk_pop" href="#legius.REF.denayer.2008.14443">Denayer et al 2008</a>]. In addition, vascular anomalies are seen in other syndromes of the Ras-MAPK pathway (i.e., capillary malformation-arteriovenous malformation syndrome with <i>RASA1</i> pathogenic variants), providing potential biologic support for an association with Legius syndrome.</p><p><b>Gene structure</b>. <i>SPRED1</i> spans 104.4 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> sequence. It consists of seven exons. The transcript is 7255 bp in length (<a href="/nuccore/187169267" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_152594.2</a>) and encodes 444 amnio acids (<a href="/protein/22749221" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_689807.1</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK47312/#legius.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Twenty-four benign or suspected benign variants have been reported in two <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>-specific databases. Ten are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, eleven are silent variants, and three are spice site variants.</p><p><a class="bk_pop" href="#legius.REF.muramzborovski.2010.1203">Muram-Zborovski et al [2010]</a> identified a common <i>SPRED1</i> haplotype matching GenBank reference sequence <a href="/nuccore/NG_008980" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NG_008980</a> in 17.9% of their NF1 cohort and 12.5% of an unselected normal population. This haplotype differs from the more common reference sequence <a href="/nuccore/NC_000015" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NC_000015</a> by four single-nucleotide variants. Two of these normal variants are in exons, one in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 3 and one in exon 7; the other two SNPs are within <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 5. See <a class="figpopup" href="/books/NBK47312/table/legius.T.selected_spred1_benign_variants/?report=objectonly" target="object" rid-figpopup="figlegiusTselectedspred1benignvariants" rid-ob="figoblegiusTselectedspred1benignvariants">Table 3</a>.</p><div id="legius.T.selected_spred1_benign_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>SPRED1</i> Benign Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47312/table/legius.T.selected_spred1_benign_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__legius.T.selected_spred1_benign_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.291A&#x0003e;G</td><td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys97Lys</td><td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/187169267" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_152594<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/22749221" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_689807<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1044C&#x0003e;T</td><td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val348Val</td></tr><tr><td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.424-8A&#x0003e;C</td><td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr><tr><td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.424-98C&#x0003e;T</td><td headers="hd_h_legius.T.selected_spred1_benign_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt></dt><dd><div><p class="no_margin">NA = not applicable</p></div></dd></dl></div></div></div><p><b>Pathogenic variants.</b> Pathogenic variants have been identified throughout <i>SPRED1</i>, without a discernible mutational hotspot. Most of the pathogenic variants identified are <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, small insertions/deletions, and gross <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> rearrangements. They are predicted to be protein truncating. A few <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have also been identified within families; however, only a portion of these have been confirmed as pathogenic using functional studies [<a class="bk_pop" href="#legius.REF.messiaen.2009.2111">Messiaen et al 2009</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Spred1 protein is a 444-amino acid sprouty-related protein. It comprises an N-terminal EVH-1 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, a central KIT binding domain, and a C-terminal SPRY domain. Spred1 belongs to a family of proteins that are negative regulators of the Ras/ERK pathway. Spred1 negatively regulates the Ras/ERK pathway by inhibiting Raf1 kinase activation [<a class="bk_pop" href="#legius.REF.wakioka.2001.647">Wakioka et al 2001</a>, <a class="bk_pop" href="#legius.REF.tidyman.2009.230">Tidyman &#x00026; Rauen 2009</a>]. Spred1 has also been shown to interact with neurofibromin to bring it to plasma membrane-bound Ras peptides [<a class="bk_pop" href="#legius.REF.stowe.2012.1421">Stowe et al 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>SPRED1</i> that result in Spred1 loss of function disrupt its ability to inhibit Raf1 kinase activation, leading to increased downstream ERK signaling. Pathogenic variants in <i>SPRED1</i> have been identified within the N-terminal EVH-1 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, the KIT binding domain, and the C-terminal SPRY domain of the spred1 protein.</p></div></div><div id="legius.References"><h2 id="_legius_References_">References</h2><div id="legius.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="legius.REF.abeliovich.1995.985">Abeliovich D, Gelman-Kohan Z, Silverstein S, Lerer I, Chemke J, Merin S, Zlotogora J. Familial cafe au lait spots: a variant of neurofibromatosis type 1. <span><span class="ref-journal">J Med Genet. </span>1995;<span class="ref-vol">32</span>:985–6.</span> [<a href="/pmc/articles/PMC1051784/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1051784</span></a>] [<a href="/pubmed/8825931" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8825931</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.arnsmeier.1994.1425">Arnsmeier SL, Riccardi VM, Paller AS. Familial multiple caf&#x000e9; au lait spots. <span><span class="ref-journal">Arch Dermatol. </span>1994;<span class="ref-vol">130</span>:1425–6.</span> [<a href="/pubmed/7979446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7979446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.brems.2007.1120">Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, Somers R, Messiaen L, De Schepper S, Fryns JP, Cools J, Marynen P, Thomas G, Yoshimura A, Legius E. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:1120–6.</span> [<a href="/pubmed/17704776" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17704776</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.brems.2012.1538">Brems H, Pasmant E, Van Minkelen R, Wimmer K, Upadhyaya M, Legius E, Messiaen L. Review and update of SPRED1 mutations causing Legius syndrome. <span><span class="ref-journal">Hum Mutat. </span>2012;<span class="ref-vol">33</span>:1538–46.</span> [<a href="/pubmed/22753041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22753041</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.brunner.1993.472">Brunner HG, Hulsebos T, Steijlen PM, der Kinderen DJ. vd Steen A, Hamel BC. Exclusion of the neurofibromatosis 1 locus in a family with inherited caf&#x000e9;-au-lait spots. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">46</span>:472–4.</span> [<a href="/pubmed/8357027" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8357027</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.charrow.1993.606">Charrow J, Listernick R, Ward K. Autosomal dominant multiple caf&#x000e9;-au-lait spots and neurofibromatosis-1: evidence of non-linkage. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">45</span>:606–8.</span> [<a href="/pubmed/8456833" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8456833</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.denayer.2008.14443">Denayer E, Ahmed T, Brems H, Van Woerden G, Borgesius NZ, Callaerts-Vegh Z, Yoshimura A, Hartmann D, Elgersma Y, D'Hooge R, Legius E, Balschun D. Spred1 is required for synaptic plasticity and hippocampus-dependent learning. <span><span class="ref-journal">J Neurosci. </span>2008;<span class="ref-vol">28</span>:14443–9.</span> [<a href="/pmc/articles/PMC6671253/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6671253</span></a>] [<a href="/pubmed/19118178" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19118178</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.denayer.2011a.e1985">Denayer E, Chmara M, Brems H, Kievit AM, van Bever Y, Van den Ouweland AM, Van Minkelen R, de Goede-Bolder A, Oostenbrink R, Lakeman P, Beert E, Ishizaki T, Mori T, Keymolen K, Van den Ende J, Mangold E, Peltonen S, Brice G, Rankin J, Van Spaendonck-Zwarts KY, Yoshimura A, Legius E. Legius syndrome in fourteen families. <span><span class="ref-journal">Hum Mutat. </span>2011a;<span class="ref-vol">32</span>:E1985–98.</span> [<a href="/pmc/articles/PMC3038325/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3038325</span></a>] [<a href="/pubmed/21089071" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21089071</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.denayer.2011b.123">Denayer E, Descheemaeker MJ, Stewart DR, Keymolen K, Plasschaert E, Ruppert SL, Snow J, Thurm AE, Joseph LA, Fryns JP, Legius E. Observations on intelligence and behavior in 15 patients with Legius syndrome. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2011b;<span class="ref-vol">157C</span>:123–8.</span> [<a href="/pmc/articles/PMC3081633/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3081633</span></a>] [<a href="/pubmed/21495177" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21495177</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.friedman.1997.138">Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">70</span>:138–43.</span> [<a href="/pubmed/9128932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9128932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.gutmann.1997.51">Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. <span><span class="ref-journal">JAMA. </span>1997;<span class="ref-vol">278</span>:51–7.</span> [<a href="/pubmed/9207339" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9207339</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.laycockvan_spyk.2011.93">Laycock-van Spyk S, Jim HP, Thomas L, Spurlock G, Fares L, Palmer-Smith S, Kini U, Saggar A, Patton M, Mautner V, Pilz DT, Upadhyaya M. Identification of five novel SPRED1 germline mutations in Legius syndrome. <span><span class="ref-journal">Clin Genet. </span>2011;<span class="ref-vol">80</span>:93–6.</span> [<a href="/pubmed/21649642" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21649642</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.messiaen.2009.2111">Messiaen L, Yao S, Brems H, Callens T, Sathienkijkanchai A, Denayer E, Spencer E, Arn P, Babovic-Vuksanovic D, Bay C, Bobele G, Cohen BH, Escobar L, Eunpu D, Grebe T, Greenstein R, Hachen R, Irons M, Kronn D, Lemire E, Leppig K, Lim C, McDonald M, Narayanan V, Pearn A, Pederson R, Powell B, Shapiro L, Skidmore D, Tegay D, Thiese H, Zackai E, Vijzelaar R, Taniguchi K, Ayada R, Okamoto F, Yoshimura A, Parret A, Korf B, Legius E. Clinical and mutational spectrum of Neurofibromatosis type 1-like syndrome. <span><span class="ref-journal">JAMA. </span>2009;<span class="ref-vol">302</span>:2111–8.</span> [<a href="/pubmed/19920235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19920235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.muramzborovski.2010.1203">Muram-Zborovski TM, Stevenson DA, Viskochil DH, Dries DC, Wilson AR, Mao Rong. SPRED 1 mutations in a neurofibromatosis clinic. <span><span class="ref-journal">J Child Neurol. </span>2010;<span class="ref-vol">25</span>:1203–9.</span> [<a href="/pmc/articles/PMC3243064/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3243064</span></a>] [<a href="/pubmed/20179001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20179001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.nih.1988.172">NIH.  National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md, USA, July 13-15, 1987. <span><span class="ref-journal">Neurofibromatosis. </span>1988;<span class="ref-vol">1</span>:172–8.</span> [<a href="/pubmed/3152465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3152465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.nystr_m.2009a.524">Nystr&#x000f6;m AM, Ekvall S, Allanson J, Edeby C, Elinder M, Holmstr&#x000f6;m G, Bondeson ML, Anner&#x000e9;n G. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1. <span><span class="ref-journal">Clin Genet. </span>2009a;<span class="ref-vol">76</span>:524–34.</span> [<a href="/pubmed/19845691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19845691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.nystr_m.2009b.693">Nystr&#x000f6;m AM, Ekvall S, Str&#x000f6;mberg B, Holmstr&#x000f6;m G, Theuresson AC, Anner&#x000e9;n G, Bondeson ML. A severe form of Noonan syndrome and autosomal dominant caf&#x000e9;-au-lait spots &#x02013; evidence for different genetic origins. <span><span class="ref-journal">Acta Paediatr. </span>2009b;<span class="ref-vol">98</span>:693–8.</span> [<a href="/pubmed/19120036" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19120036</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.pasmant.2009.1131">Pasmant E, Ballerini P, Lapillonne H, Perot C, Vidaud D, Leverger G, Landman-Parker J. SPRED1 disorder and predisposition to leukemia in children. <span><span class="ref-journal">Blood. </span>2009;<span class="ref-vol">114</span>:1131.</span> [<a href="/pubmed/19643996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19643996</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.pasmant.2015.631">Pasmant E, Gilbert-Dussardier B, Petit A, de Laval B, Luscan A, Gruber A, Lapillonne H, Deswarte C, Goussard P, Laurendeau I, Uzan B, Pflumio F, Brizard F, Vabres P, Naguibvena I, Fasola S, Millot F, Porteu F, Vidaud D, Landman-Parker J, Ballerini P. SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumor suppressor downregulated in paediatric acute myeloblastic leukaemia. <span><span class="ref-journal">Oncogene. </span>2015;<span class="ref-vol">34</span>:631–8.</span> [<a href="/pubmed/24469042" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24469042</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.spencer.2011.1352">Spencer E, Davis J, Mikhail F, Fu C, Vijzelaar R, Zackai EH, Feret H, Meyn MS, Shugar A, Bellus G, Kocsis K, Kivirikko S, P&#x000f6;yh&#x000f6;nen M, Messiaen L. Identification of SPRED1 deletions using RT-PCR, multiplex ligation-dependent probe amplification and quantitative PCR. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:1352–9.</span> [<a href="/pubmed/21548021" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21548021</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.spurlock.2009.431">Spurlock G, Bennett E, Chuzhanova N, Thomas N, Jim HP, Side L, Davies S, Haan E, Kerr B, Huson SM, Upadhyaya M. SPRED1 mtuations (Legius syndrome): another clinically useful genotype for dissecting the NF1 phenotype. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:431–7.</span> [<a href="/pubmed/19443465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19443465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.stevenson.2009.2150">Stevenson D, Viskochil D. Pigmentary findings in neurofibromatosis type 1-like syndrome (Legius syndrome): potential diagnostic dilemmas. <span><span class="ref-journal">JAMA. </span>2009;<span class="ref-vol">302</span>:2150–1.</span> [<a href="/pubmed/19920242" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19920242</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.stevenson.2006.246">Stevenson DA, Viskochil DH, Rope AF, Carey JC. Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype. <span><span class="ref-journal">Clin Genet. </span>2006;<span class="ref-vol">69</span>:246–53.</span> [<a href="/pmc/articles/PMC3243644/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3243644</span></a>] [<a href="/pubmed/16542390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16542390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.stowe.2012.1421">Stowe IB, Mercado EL, Stowe TR, Bell EL, Oses-Prieto JA, Hern&#x000e1;ndez H, Burlingame AL, McCormick F. A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibormatosis-1. <span><span class="ref-journal">Genes Dev. </span>2012;<span class="ref-vol">26</span>:1421–6.</span> [<a href="/pmc/articles/PMC3403010/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3403010</span></a>] [<a href="/pubmed/22751498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22751498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.tidyman.2009.230">Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. <span><span class="ref-journal">Curr Opin Genet Dev. </span>2009;<span class="ref-vol">19</span>:230–6.</span> [<a href="/pmc/articles/PMC2743116/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2743116</span></a>] [<a href="/pubmed/19467855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19467855</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.upadhyaya.2007.140">Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans DG, Howard E, Kerr B, Griffiths S, Consoli C, Side L, Adams D, Pierpoint M, Hachen R, Barnicoat A, Li H, Wallace P, Stevenson D, Viskochil D, Baralle D, Haan E, Turnpenny P, Riccardi V, Lazaro C, Messiaen L. An absence of cutaneous neurofibroma associated with a 3-bp in-frame deletion in exon 17 of the NF1 gene (c.2970_2972 delAAT): Evidence of a clinically significant NF1 genotype-phenotype correlation. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">80</span>:140–51.</span> [<a href="/pmc/articles/PMC1785321/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1785321</span></a>] [<a href="/pubmed/17160901" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17160901</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="legius.REF.wakioka.2001.647">Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K, Tsuneoka M, Komiya S, Baron R, Yoshimura A. Spred is a Sprouty-related suppressor of Ras signaling. <span><span class="ref-journal">Nature. </span>2001;<span class="ref-vol">412</span>:647–51.</span> [<a href="/pubmed/11493923" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11493923</span></a>]</div></li></ul></div></div><div id="legius.Chapter_Notes"><h2 id="_legius_Chapter_Notes_">Chapter Notes</h2><div id="legius.Acknowledgments"><h3>Acknowledgments</h3><p>John Carey, MD; Ludwine Messiaen, PhD; Talia Muram, MD</p></div><div id="legius.Author_History"><h3>Author History</h3><p>Rong Mao, MD (2010-present)<br />Talia Muram-Zborovski, MD, University of Utah (2010-2015)<br />David Stevenson, MD (2010-present)<br />David Viskochil, MD, PhD (2010-present)</p></div><div id="legius.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>15 January 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 May 2011 (cd) Revision: Testing Strategy; <a class="figpopup" href="/books/NBK47312/table/legius.T.additional_findings_reported_in/?report=objectonly" target="object" rid-figpopup="figlegiusTadditionalfindingsreportedin" rid-ob="figoblegiusTadditionalfindingsreportedin">Table 2</a></div></li><li class="half_rhythm"><div>14 October 2010 (me) Review posted live</div></li><li class="half_rhythm"><div>29 April 2010 (ds) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK47312</span><span class="label">PMID: <a href="/pubmed/20945555" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20945555</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lhon/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lenz/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK47312&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK47312/?report=reader">PubReader</a></li><li><a href="/books/NBK47312/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK47312" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK47312" style="display:none" title="Cite this Page"><div class="bk_tt">Stevenson D, Viskochil D, Mao R. Legius Syndrome. 2010 Oct 14 [Updated 2015 Jan 15]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK47312/pdf/Bookshelf_NBK47312.pdf">PDF version of this page</a> (213K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#legius.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#legius.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#legius.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#legius.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#legius.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#legius.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#legius.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#legius.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#legius.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#legius.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#legius.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=161742[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SPRED1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK47312+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2337840" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2337840" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2337840" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2337840" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22384355" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The SPRED1 Variants Repository for Legius Syndrome.</a><span class="source">[G3 (Bethesda). 2011]</span><div class="brieflinkpop offscreen_noflow">The SPRED1 Variants Repository for Legius Syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sumner K, Crockett DK, Muram T, Mallempati K, Best H, Mao R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">G3 (Bethesda). 2011 Nov; 1(6):451-6. Epub 2011 Nov 1.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26635368" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.</a><span class="source">[J Biol Chem. 2016]</span><div class="brieflinkpop offscreen_noflow">Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hirata Y, Brems H, Suzuki M, Kanamori M, Okada M, Morita R, Llano-Rivas I, Ose T, Messiaen L, Legius E, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Biol Chem. 2016 Feb 12; 291(7):3124-34. Epub 2015 Dec 3.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/19920235" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.</a><span class="source">[JAMA. 2009]</span><div class="brieflinkpop offscreen_noflow">Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Messiaen L, Yao S, Brems H, Callens T, Sathienkijkanchai A, Denayer E, Spencer E, Arn P, Babovic-Vuksanovic D, Bay C, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">JAMA. 2009 Nov 18; 302(19):2111-8. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24334617" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Legius syndrome, an Update. Molecular pathology of mutations in SPRED1.</a><span class="source">[Keio J Med. 2013]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Legius syndrome, an Update. Molecular pathology of mutations in SPRED1.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brems H, Legius E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Keio J Med. 2013; 62(4):107-12. Epub 2013 Dec 10.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301288" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neurofibromatosis 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neurofibromatosis 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Friedman JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20945555" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20945555" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04177bdde0891169270598">Legius Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Legius Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:14:19-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D6F4FE040482100000000082102DF&amp;ncbi_session=CE8D6F4FE04177A1_2081SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK47312%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK47312&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK47312/&amp;ncbi_pagename=Legius Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D6F4FE04177A1_2081SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>